TECHWIRE 30
(CIX: WRAL30)  1,106.38    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NQ: Apple)  100.75    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NY: QUINTILES)  55.78    (0 %)  Updated: 06:40 PM EDT, Sep 30 2014
(OP: BASF SE)  91.57    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NQ: BioCryst)  9.78    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NQ: BioDelivery)  17.09    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NQ: CEMP)  10.96    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NQ: Cisco Systems)  25.17    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NQ: Cree)  40.95    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NQ: DARA)  1.08    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NY: EMC CORPORATION)  29.26    (0 %)  Updated: 06:40 PM EDT, Sep 30 2014
(NQ: Extreme Networks)  4.79    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NQ: FB)  79.04    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NY: GLAXOSMITHKLINE)  45.97    (0 %)  Updated: 06:40 PM EDT, Sep 30 2014
(NQ: GOOG)  577.36    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NY: IBM)  189.83    (0 %)  Updated: 06:40 PM EDT, Sep 30 2014
(NY: LH)  101.75    (0 %)  Updated: 06:40 PM EDT, Sep 30 2014
(OP: Lenovo Group)  29.75    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NY: MRK)  59.28    (0 %)  Updated: 06:40 PM EDT, Sep 30 2014
(NQ: Microsoft Corp)  46.36    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NQ: NTAP)  42.96    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NY: NOVARTIS AG)  94.13    (0 %)  Updated: 06:40 PM EDT, Sep 30 2014
(OP: Novozymes A/S)  43.24    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NY: PFIZER)  29.57    (0 %)  Updated: 06:40 PM EDT, Sep 30 2014
(NQ: Pozen)  7.34    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NY: RED HAT)  56.15    (0 %)  Updated: 06:40 PM EDT, Sep 30 2014
(NQ: BBRY)  9.94    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NQ: Salix)  156.24    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014
(NQ: SQI)  15.04    (0 %)  Updated: 08:10 PM EDT, Sep 30 2014

Posts tagged “Biotech & Life Science”

1:15 p.m. yesterday

GSK pledges $5M for startups; UNC, Duke scientists land grants for BRAIN Initiative

President Obama's BRAIN Initiative - Brain Research through Advancing Innovative Neurotechnologies - second year kickoff includes three RTP connections: Funding from GlaxoSmithKline and research grants for teams at UNC-Chapel Hill as well as Duke.

An NIH look at the brain  An NIH look at the brain

12:06 p.m. yesterday

Premium Lock Murdock commits $15M 'in perpetuity' to support NC Research Campus

David Murdock, the 91-year-old billionaire founder of the North Carolina Research Campus, sets aside $15 million annually from his estate with the goal of advancing life science research for years to come. But the feisty Murdock says he still aims to live to 125.

David Murdock  David Murdock

10:00 a.m. yesterday

Pearl Therapeutics expanding, adding jobs in Durham

IT jobs Pearl Therapeutics, a California-based respiratory drug development subsidiary of AstraZeneca, is hiring and expanding its Durham operations.

8:16 a.m. yesterday

Robotic surgery firm TransEnterix secures $25M loan

TransEnterix TransEnterix, a developer of robotic and flexible instrument technology for use in surgery, has landed a loan worth up to $25 million. The deal provides "up to three quarters of additional capital to satisfy our operating cash requirements," says CEO.

Updated 7:56 a.m. yesterday

Premium Lock Source: Murdock making $50M-plus gift to NC Research Campus

The billionaire founder of the North Carolina Research Campus will make the gift announcement Tuesday to continue supporting operational expenses and recruit top scientific talent to the state. It's his second large donation by the 91-year-old in the last 16 months.

David Murdock David Murdock

Updated 11:56 a.m. Monday

Massive redevelopment project coming to downtown Durham

A team of developers led by Longfellow Real Estate Partners from Boston, Duke University and Durham businessman Hank Scherich will unveil formal plans Wednesday for the "Durham Innovation District." The project is expected to cost hundreds of millions of dollars and cover 1.7 million square feet of office space.

The Carmichael Building The Carmichael Building

Updated 11:21 a.m. Monday

Premium Lock CRO Chiltern expands into Asia-Pacific with latest acquisition

Chiltern The acquisition of Pacific Clinical Research in Singapore comes after Chiltern's purchase of Ockham in July, expanding the company's operations and therapeutic depth in Asia-Pacific.

10:38 a.m. Monday

Duke spin-off Regado Biosciences cuts workforce - again

Regado The termination of clinical trials of its blood clotting drug REGULATE-PCI in July coupled with struggling stock prices prompts the company to rethink its strategic direction.

6:50 a.m. Monday

Latest news on Cisco Intercloud, Windows 9, Ello goes viral, Yahoo! Directory and Healthy Selfies

Bulldog In the latest Bulldog roundup of life science and technology news: Cisco Intercloud partner ecosystem expanded with $1 billion in new financing; Microsoft offers first look at new Windows this week; Anti-Facebook social network Ello goes viral; Yahoo! Directory is shutting down this year; and what can doctors can learn from our Selfies?

6:26 a.m. Monday

Your 56 WRAL TechWire headlines from last week

Week in review Some local websites run one or two tech stories per day. Others a few more but mixed with a variety of business news. At WRAL TechWire, tech and life science make up the menu with more than 50 stories published over the last five business days. Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week.

Updated 6:14 a.m. Monday

Have news? Share it with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

September 26

#WTWTrends for Friday: Shellshock, Best Places to Work, IBM trending in the Triangle

Trending in the Triangle Get the pulse of technology in the Triangle with the best in local technology, venture, biotech, and life science news on Friday as curated by @WRALTechWire.

September 26

PPD buys remaining interest in firm it has owned since 2010

PPD Wilmington-based PPD, which has a large presence in the Triangle, on Thursday bought the remaining minority interest in a Massachusetts firm which it originally acquired in 2010.

September 25

#WTWTrends for Thursday: Red Hat's Bash Bug, Novartis, LabCorp, Sageworks spark social discussions

Trending in the Triangle Trending in the Triangle: Get the pulse of technology in the Triangle with the best in local technology, venture, biotech, and life science news on Thursday as curated by @WRALTechWire.

September 25

GSK confirms bank exec to take over as board chairman

GSK  Drug giant GlaxoSmithKline will have a new chairman a year from now: Philip Hampton, the current chair at Royal Bank of Scotland Group. Hampton will first join the GSK board as of Jan. 1 as a director.

Updated September 25

LabCorp to acquire Raleigh-based LipoScience in $85M deal

DNA    Lab testing giant LabCorp, which is based in Burlington, is acquiring Triangle-based LipoScience in a deal worth some $85 million in cash. The deal sends LipoScience shares up 60 percent.

Updated September 25

New GSK chairman; Lenovo stock pressure; FTC bitcoin crackdown; FAA to OK drones; Cree's new competition

Bulldog In today's wrapup of life science and technology news: GSK is getting a new chairman in wake of the China bribery scandal, says The Times of London; Lenovo stock faces price pressure; FTC takes aim at bitcoins; FAA to OK drones for Hollywood; Cree's new competition from Philips.

September 25

Novartis ships first of new-type flu vaccine from Holly Springs plant

Pharmaceutical maker Novartis on Wednesday celebrated the U.S. Food and Drug Administration's licensing and first shipments of a new flu vaccine that the company says could drastically help with reducing a potential pandemic.

Rep. Renee Ellmers Rep. Renee Ellmers

Updated September 24

Novartis dedicates $1B vaccine plant with VIP flu shots as NC exec who recruited the firm will watch

It's probably a safe bet that Gov. Pat McCrory has already received his flu shot for the 2014-5 season, but he and other VIPs can line up for vaccinations today as Novartis formally dedicates production at its mammoth $1 billion plant in Holly Springs. But there's also an interesting back story to the event: The N.C. Biotechnology Center exec who helped recruit Novartis to N.C. way back in 2006.

Novartis plant in Holly Springs Novartis plant in Holly Springs

Updated September 24

$10B deal? Sale talk drives Salix shares to record high

Salix   Raleigh-based Salix Pharmaceuticals is talking a possible deal with Allergan, according to multiple media reports. A deal would be worth $10 billion or more as speculation drives up the price of Salix shares to a record high.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll